My Companies
Notification
Account
Log Out
Login
Lords Mark entered a collaboration with ARKALL Holdings to establish pathology laboratories and commercialise MedTech across 28 Caribbean markets. ARKALL will fund expansion, while Lords Mark supplies products and technical support. Management projects ~US$100 million in FY27–FY31 export revenue, subject to approvals and execution. Context: broadens international healthcare rollout.
Lord's Mark Unveils ₹1,550 Crore FY27 Guidance And Healthcare Expansion
Lord's Mark Receives India's First Biomescan SaMD Manufacturing Licence
Lord's Mark Industries Approves In-Principle MPS Plan With OFS And Rights Issue
Lords Mark Industries Commissions Vasai IVD Facility Two Months Early